Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · IEX Real-Time Price · USD
1.790
+0.170 (10.49%)
Feb 26, 2024, 1:33 PM EST - Market open

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2022202120202019
Market Capitalization
1053281--
Market Cap Growth
--60.18%---
Enterprise Value
65-1116-11-5
PE Ratio
-2.77-1.44-3.29--
PS Ratio
--1323.13--
PB Ratio
3.030.851.37--
P/FCF Ratio
-2.79-1.63-4.42--
P/OCF Ratio
-2.80-1.63-4.43--
EV/Sales Ratio
--259.37--
EV/EBITDA Ratio
-1.340.49-0.650.680.50
EV/EBIT Ratio
-1.330.48-0.650.670.49
EV/FCF Ratio
-1.340.55-0.871.510.57
Debt / Equity Ratio
0.010.000.000.010.01
Debt / EBITDA Ratio
-0.010.000.00-0.01-0.01
Debt / FCF Ratio
-0.010.000.00-0.02-0.02
Quick Ratio
5.086.117.295.6611.42
Current Ratio
5.296.277.545.9420.81
Asset Turnover
000.000-
Return on Equity (ROE)
-65.40%-50.90%-70.70%-147.70%-
Return on Assets (ROA)
-54.70%-43.60%-61.00%-131.50%-
Return on Capital (ROIC)
-88.02%-79.07%-50.64%-154.10%-95.05%
Earnings Yield
-26.55%-69.65%-30.36%--
FCF Yield
-26.30%-61.46%-22.60%--
Buyback Yield / Dilution
-3.45%-44.61%-44.77%-15.63%-
Total Shareholder Return
-3.45%-44.61%-44.77%-15.63%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).